GDF3 and metabolic dysfunction-associated steatohepatitis: Interestingly, hepatic GDF3 expression was significantly increased in patients with NASH (Fig. 3a), but it was unchanged in patients with alcoholic hepatitis, autoimmune hepatitis, drug-induced liver injury, and hepatitis B virus infection (Fig. 3a).